FDA could intensify focus on medtech cybersecurity in 2026
The FDA’s cybersecurity dictates around premarket applications’ have been in effect since 2023, with more post-market oversight expected next year.
Explore our marketing solutions
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
